Bio-Rad Labs (BIO) Reports Q4 EPS of $1.34
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $362.08 +1.64%
Financial Fact:
Net income attributable to Bio-Rad: 18.01M
Today's EPS Names:
MTEX, NSYS, PLNH, More
Financial Fact:
Net income attributable to Bio-Rad: 18.01M
Today's EPS Names:
MTEX, NSYS, PLNH, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q4 EPS of $1.34, may not compare to the analyst estimate of $1.18. Revenue for the quarter came in at $598.2 million versus the consensus estimate of $593.41 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance
- SeaStar Medical (ICU) Misses Q1 EPS by 4c
- Logistic Properties of the Americas (LPA) Reports Q2 results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
